1. Research framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Executive Summary
3. Japan HealthTech Market Insights
3.1. Industry Value Chain Analysis
3.2. DROC Analysis
3.2.1. Growth Drivers
3.2.1.1. Japan's Rapidly Aging Population
3.2.1.2. Increased Demand for Medical and Nursing Care in Urban Areas
3.2.1.3. Labor Shortage in the Medical and Nursing Care Sectors
3.2.1.4. COVID-19 Pandemic has Accelerated the Need for Digital Health Solutions
3.2.2. Restraints
3.2.2.1. Immature Reimbursement System for Digital Health Solutions
3.2.2.2. Elderly Population has Limited Income, Making it Difficult to Monetize Solutions
3.2.2.3. Language Barrier, as Most People don't Speak English
3.2.3. Opportunities
3.2.3.1. Telemedicine, E-Prescriptions, and Reimbursement for Digital Health Apps will be Game-Changers
3.2.3.2. Wellness and Preventive Medicine Segments are Attractive, as People are Willing to Pay Out-Of-Pocket
3.2.3.3. Japanese Life Insurers are Investing in Digital Health Solutions and Conducting M&A
3.2.3.4. Harmonization of Regulations with the U.S. is Making Market Entry Easier for Medical Devices
3.2.4. Challenges
3.2.4.1. Balancing Tech Push with Patient Pull and Understanding the Local Problem and Value Proposition
3.2.4.2. Developing Innovative, Profitable Business Models suited to the Japanese Market
3.2.4.3. Finding the Right Local Partner for Distribution, Promotion, and Market Access
3.2.4.4. Navigating the Regulatory Approval Process and Reimbursement System
3.3. Technological Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter's Five Forces Analysis
3.5.1. Bargaining Power of Suppliers
3.5.2. Bargaining Power of Buyers
3.5.3. Threat of New Entrants
3.5.4. Threat of Substitutes
3.5.5. Intensity of Rivalry
4. Japan HealthTech Market: Marketing Strategies
5. Japan HealthTech Market Overview
5.1. Market Size & Forecast, 2019-2030
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1. By Technology
5.2.1.1. Digital Health Systems
5.2.1.2. Health Analytics
5.2.1.3. Health Information Technology
5.2.1.4. mHealth
5.2.1.5. Telehealthcare
5.2.2. By Component
5.2.2.1. Hardware
5.2.2.2. Software
5.2.2.3. Services
5.2.3. By Application
5.2.3.1. Cardiology
5.2.3.2. Diabetes
5.2.3.3. Neurology
5.2.3.4. Sleep Apnea
5.2.3.5. Oncology
5.2.3.6. Others
5.2.4. By End User
5.2.4.1. Healthcare Providers
5.2.4.2. Healthcare Payers
5.2.4.3. Healthcare Consumers
5.2.4.4. Pharmaceutical Companies
5.2.4.5. Others
6. Competitive Landscape
6.1. List of Key Players and Their Range
6.2. Japan HealthTech Company Market Share Analysis, 2023
6.3. Competitive Benchmarking, By Operating Parameters
6.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships)
7. Impact of Escalating Geopolitical Tensions on Japan HealthTech Market Industry
8. Company Profiles (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook, and SWOT Analysis)
8.1. Allm Inc.
8.2. M3, Inc.
8.3. Omron
8.4. Whill
8.5. FiNC
8.6. CureApp
8.7. AI Medical Service
8.8. Awarefy
8.9. iCARE
8.10. Other prominent players
9. Key Strategic Recommendations
10. Research Methodology
10.1. Qualitative Research
10.1.1. Primary & Secondary Research
10.2. Quantitative Research
10.3. Market Breakdown & Data Triangulation
10.3.1. Secondary Research
10.3.2. Primary Research
10.4. Breakdown of Primary Research Respondents
10.5. Assumption & Limitation
*Financial information of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable.